Neoadjuvant chemotherapy: are we barking up the right tree?

被引:9
作者
Debled, M. [1 ]
Mauriac, L. [1 ]
机构
[1] Reg Canc Ctr, Inst Bergonie, Dept Med Oncol, Bordeaux, France
关键词
OPERABLE BREAST-CANCER; PATHOLOGICAL COMPLETE RESPONSE; EPIRUBICIN PLUS DOCETAXEL; COLONY-STIMULATING FACTOR; III RANDOMIZED GEPARTRIO; PHASE-III; PREOPERATIVE CHEMOTHERAPY; SYSTEMIC THERAPY; RESIDUAL DISEASE; CYCLES;
D O I
10.1093/annonc/mdq062
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:675 / 679
页数:5
相关论文
共 38 条
[31]   Pathologic complete response with six compared with three cycles of Neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer:: Results of ABCSG-14 [J].
Steger, Guenther G. ;
Galid, Arik ;
Gnant, Michael ;
Mlineritsch, Brigitte ;
Lang, Alois ;
Tausch, Christoph ;
Rudas, Margaretha ;
Greil, Richard ;
Wenzel, Catharina ;
Singer, Christian F. ;
Haid, Anton ;
Poestlberger, Sabine ;
Samonigg, Hellmut ;
Luschin-Ebengreuth, Gera ;
Kwasny, Werner ;
Klug, Eduard ;
Kubista, Ernst ;
Menzel, Christian ;
Jakesz, Rainiund .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) :2012-2018
[32]   Measurement of residual breast cancer burden to predict survival after Neoadjuvant chemotherapy [J].
Symmans, W. Fraser ;
Peintinger, Florentia ;
Hatzis, Christos ;
Rajan, Radhika ;
Kuerer, Henry ;
Valero, Vicente ;
Assad, Lina ;
Poniecka, Anna ;
Hennessy, Bryan ;
Green, Marjorie ;
Buzdar, Aman U. ;
Singletary, S. Eva ;
Hortobagyi, Gabriel N. ;
Pusztai, Lajos .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (28) :4414-4422
[33]   The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: Long-term results from a prospective randomized trial [J].
Thomas, E ;
Holmes, FA ;
Smith, TL ;
Buzdar, AU ;
Frye, DK ;
Fraschini, G ;
Singletary, SE ;
Theriault, RL ;
McNeese, MD ;
Ames, F ;
Walters, R ;
Hortobagyi, GN .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2294-2302
[34]   Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer [J].
Untch, Michael ;
Moebus, Volker ;
Kuhn, Walther ;
Muck, Bernd Rudolph ;
Thomssen, Christoph ;
Bauerfeind, Ingo ;
Harbeck, Nadia ;
Werner, Christoph ;
Lebeau, Annette ;
Schneeweiss, Andreas ;
Kahlert, Stephen ;
von Koch, Franz ;
Petry, Karl Ulrich ;
Wallwiener, Diethelm ;
Kreienberg, Rolf ;
Albert, Ute-Susann ;
Lueck, Hans-Joachim ;
Hinke, Axel ;
Jaenicke, Fritz ;
Konecny, Gottfried E. .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (18) :2938-2945
[35]   Intensified neoadjuvant chemotherapy in early-responding breast cancer:: Phase III randomized GeparTrio study [J].
von Minckwitz, Gunter ;
Kuemmel, Sherko ;
Vogel, Petra ;
Hanusch, Claus ;
Eidtmann, Holger ;
Hilfrich, Joern ;
Gerber, Bernd ;
Huober, Jens ;
Costa, Serban Dan ;
Jackisch, Christian ;
Loibl, Sibylle ;
Mehta, Keyur ;
Kaufmann, Manfred .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (08) :552-562
[36]   Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer:: Phase III randomized GeparTrio trial [J].
von Minckwitz, Gunter ;
Kuemmel, Sherko ;
Vogel, Petra ;
Hanusch, Claus ;
Eidtmann, Holger ;
Hilfrich, Joern ;
Gerber, Bernd ;
Huober, Jens ;
Costa, Serban Dan ;
Jackisch, Christian ;
Loibl, Sibylle ;
Mehta, Keyur ;
Kaufmann, Manfred .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (08) :542-551
[37]   Research issues affecting preoperative systemic therapy for operable breast cancer [J].
Wolff, Antonio C. ;
Berry, Donald ;
Carey, Lisa A. ;
Colleoni, Marco ;
Dowsett, Mitchell ;
Ellis, Matthew ;
Garber, Judy E. ;
Mankoff, David ;
Paik, Soonmyung ;
Pusztai, Lajos ;
Smith, Mary Lou ;
Zujewski, JoAnne .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (05) :806-813
[38]  
Wolmark N, 2001, J Natl Cancer Inst Monogr, P96